日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A glycolytic metabolite bypasses "two-hit" tumor suppression by BRCA2

糖酵解代谢物绕过 BRCA2 的“二次打击”肿瘤抑制

Li Ren Kong, Komal Gupta, Andy Jialun Wu, David Perera, Roland Ivanyi-Nagy, Syed Moiz Ahmed, Tuan Zea Tan, Shawn Lu-Wen Tan, Alessandra Fuddin, Elayanambi Sundaramoorthy, Grace Shiqing Goh, Regina Tong Xin Wong, Ana S H Costa, Callum Oddy, Hannan Wong, C Pawan K Patro, Yun Suen Kho, Xiao Zi Huang, J

Super enhancer acquisition drives expression of oncogenic PPP1R15B that regulates protein homeostasis in multiple myeloma

超级增强子获得驱动致癌基因 PPP1R15B 的表达,该基因在多发性骨髓瘤中调节蛋白质稳态。

Sinan Xiong ,Jianbiao Zhou ,Tze King Tan ,Tae-Hoon Chung ,Tuan Zea Tan ,Sabrina Hui-Min Toh ,Nicole Xin Ning Tang ,Yunlu Jia ,Yi Xiang See ,Melissa Jane Fullwood ,Takaomi Sanda ,Wee-Joo Chng

Super-enhancer-driven TOX2 mediates oncogenesis in Natural Killer/T Cell Lymphoma

超级增强子驱动的 TOX2 介导自然杀伤/T 细胞淋巴瘤的致癌作用

Jianbiao Zhou, Sabrina Hui-Min Toh, Tze King Tan, Kalpnaa Balan, Jing Quan Lim, Tuan Zea Tan, Sinan Xiong, Yunlu Jia, Siok-Bian Ng, Yanfen Peng, Anand D Jeyasekharan, Shuangyi Fan, Soon Thye Lim, Chin-Ann Johnny Ong, Choon Kiat Ong, Takaomi Sanda, Wee-Joo Chng

SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition

SHP2 抑制剂通过抑制 SMURF2 来维持 TGFβ 信号传导

Xianning Lai #, Sarah Kit Leng Lui #, Hiu Yan Lam #, Yuta Adachi, Wen Jing Sim, Natali Vasilevski, Nicola J Armstrong, Stephanie Claire Bridgeman, Nathan Michael Main, Tuan Zea Tan, Janina E E Tirnitz-Parker, Jean Paul Thiery, Hiromichi Ebi, Alan Prem Kumar, Pieter Johan Adam Eichhorn

Nuclear pCHK1 as a potential biomarker of increased sensitivity to ATR inhibition

核 pCHK1 是 ATR 抑制敏感性增加的潜在生物标志物

Vignesh Sundararajan, Tuan Zea Tan, Diana Lim, Yanfen Peng, Antje Margret Wengner, Natalie Yan Li Ngoi, Anand D Jeyasekharan, David Shao Peng Tan

The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer

抑制受体酪氨酸激酶AXL对卵巢癌DNA损伤反应的影响

Xun Hui Yeo, Vignesh Sundararajan, Zhengwei Wu, Zi Jin Cheryl Phua, Yin Ying Ho, Kai Lay Esther Peh, Yi-Chia Chiu, Tuan Zea Tan, Dennis Kappei, Ying Swan Ho, David Shao Peng Tan, Wai Leong Tam, Ruby Yun-Ju Huang

BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer

BCG 疗法下调恶性细胞上的 HLA-I,从而破坏膀胱癌的抗肿瘤免疫反应

Mathieu Rouanne, Julien Adam, Camélia Radulescu, Diane Letourneur, Delphine Bredel, Séverine Mouraud, Anne-Gaëlle Goubet, Marion Leduc, Noah Chen, Tuan Zea Tan, Nicolas Signolle, Amélie Bigorgne, Michael Dussiot, Lambros Tselikas, Sandrine Susini, François-Xavier Danlos, Anna K Schneider, Roman Chab

3D genome organization in the epithelial-mesenchymal transition spectrum

上皮-间质转变谱中的三维基因组组织

Qing You Pang, Tuan Zea Tan, Vignesh Sundararajan, Yi-Chia Chiu, Edward Yu Wing Chee, Vin Yee Chung, Mahesh A Choolani, Ruby Yun-Ju Huang

PI3Kδ activity controls plasticity and discriminates between EMT and stemness based on distinct TGFβ signaling

PI3Kδ 活性控制可塑性,并根据不同的 TGFβ 信号区分 EMT 和干性

Jean Agnetti #, Vanessa Bou Malham #, Christophe Desterke #, Nassima Benzoubir, Juan Peng, Sophie Jacques, Souad Rahmouni, Emanuel Di Valentin, Tuan Zea Tan, Didier Samuel, Jean Paul Thiery, Ama Gassama-Diagne

Osteopontin (OPN/SPP1), a Mediator of Tumor Progression, Is Regulated by the Mesenchymal Transcription Factor Slug/SNAI2 in Colorectal Cancer (CRC)

骨桥蛋白 (OPN/SPP1) 是一种肿瘤进展介质,受结直肠癌 (CRC) 中的间充质转录因子 Slug/SNAI2 调控

Katyana Amilca-Seba, Tuan Zea Tan, Jean-Paul Thiery, Lila Louadj, Sandrine Thouroude, Anaïs Bouygues, Michèle Sabbah, Annette K Larsen, Jérôme A Denis